Topics Range from Industry Status to a Preview of May’s “BIO 2010” Conference in Chicago James Greenwood is president and CEO of the Biotechnology Industry Organization in Washington, D.C. BIO ...
Dr. Guy Chamberland, M.Sc., Ph.D., Master Herbalist, has served as Tetra Bio-Pharma’s Chief Executive Officer and Chief Regulatory Officer since October 15, 2018. Dr. Chamberland is a drug development ...
WASHINGTON — BIO’s new CEO John Crowley is making changes. He’s pivoting the biotechnology industry’s largest trade association away from a focus on controversial social issues. He dramatically ...
Drawing on over 50 years of drug development experience, Dr. Hausman strengthens the Company’s mission to combat cancer and other serious diseases. In the discussion, Hausman highlighted his career ...
The Massachusetts biotech ElevateBio raised $525 million in an industry-record Series C round. The company produces cell- and gene-therapy medicines and is also now making its own research bets. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results